Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,148 | 5,358 | 9,624 | 26,272 | 11,649 |
| Marketable Securities | 59,637 | 78,464 | 87,330 | 83,974 | 30,924 |
| Receivables | 14,590 | 9,771 | 7,756 | 5,243 | 4,352 |
| Inventories | 15,557 | 15,606 | 14,221 | 10,760 | 12,077 |
| TOTAL | $106,751 | $111,685 | $121,490 | $128,989 | $60,922 |
| Non-Current Assets | |||||
| PPE Net | 48,182 | 45,944 | 42,065 | 41,130 | 39,116 |
| Intangibles | 11,485 | 11,209 | 11,163 | 11,277 | 11,505 |
| Other Non-Current Assets | 3,402 | 3,557 | 3,712 | 3,845 | 511 |
| TOTAL | $63,069 | $60,710 | $56,940 | $56,252 | $51,132 |
| Total Assets | $169,820 | $172,395 | $178,430 | $185,241 | $112,054 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,069 | 1,559 | 1,712 | 1,001 | 2,569 |
| Accrued Expenses | 17,885 | 15,573 | 12,260 | 9,872 | 9,792 |
| Other current liabilities | 1,020 | 941 | 891 | 853 | 823 |
| TOTAL | $121,943 | $116,972 | $15,835 | $12,698 | $14,156 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 96,892 | 95,857 | 25,191 |
| Deferred Revenues | 1,008 | 972 | 972 | 972 | 972 |
| Other Non-Current Liabilities | 3,416 | 3,314 | 3,327 | 3,417 | 3,132 |
| TOTAL | $6,628 | $6,305 | $103,453 | $102,751 | $32,043 |
| Total Liabilities | $128,571 | $123,277 | $119,288 | $115,449 | $46,199 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,714 | 33,539 | 33,316 | 33,047 | 32,656 |
| Common Shares | 34 | 34 | 33 | 33 | 33 |
| Retained earnings | -296,429 | -284,473 | -269,689 | -255,658 | -232,520 |
| Other shareholders' equity | 5 | 15 | 11 | 42 | 25 |
| TOTAL | $41,249 | $49,118 | $59,142 | $69,792 | $65,855 |
| Total Liabilities And Equity | $169,820 | $172,395 | $178,430 | $185,241 | $112,054 |